Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Proteinarrays.bio is a professional scientific research service website operated by German biomarker company engine, with protein microarray technology inherited from the RZPD project of the Human Genome Project in Germany. It provides high-throughput screening services based on high-density human protein arrays for global biomedical research teams, with core businesses focusing on two major areas: novel biomarker discovery and antibody specificity off-target detection.
The platform's core products are two standard high-density protein chips: hEXselect and UniPEx. They cover more than 15,000 types of human full-length antigens, protein isoforms and peptides, and host the world's largest library of neoantigens and frameshift peptides. The service adopts an all-inclusive model: users only need to provide 50 μl of any matrix sample (serum, cerebrospinal fluid, cell supernatant, etc. are all acceptable), and the platform completes the entire chip screening process. It delivers scientific reports including interaction analysis, antigen identification and raw data within 2 weeks, and can also provide customized subchips for subsequent candidate biomarker validation.
Pricing is transparent and itemized: 1100 EUR per standard chip, 560 EUR for single-chip screening service, 1000 EUR for result organization per order. Discounts are available for bulk projects, and customized services can be quoted separately upon request.
Pros: The platform's technology originates from the Max Planck Institute, with over 25 years of technical accumulation. The technical results of the platform have been used in more than 100 academic publications, and its technical reliability has been validated in the field. Its hypothesis-free unbiased screening model does not rely on existing research hypotheses, which is more conducive to the discovery of completely novel biomarkers. It only requires a small volume of sample to complete whole-proteome screening, and its efficiency is dozens of times higher than traditional single-antigen research.
Cons: The overall service cost is relatively high, making it more suitable for projects with sufficient funding; the platform only provides English service with no Chinese interface, which creates a certain barrier for domestic Chinese teams to cooperate; it only provides screening services and does not cover downstream validation steps.
This platform is suitable for university research teams conducting innovative biomarker research in fields such as oncology, autoimmune diseases, and neurobiology, as well as diagnostic reagent companies conducting off-target detection for antibody drugs. Currently, users in China can access the website directly, no VPN required.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on proteinarrays.bio official site.
proteinarrays.bio is an overseas Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of China direct-connect friendly. Click "Visit Official Site" to reach proteinarrays.bio directly.